Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Association betweenInternational journal of environmental research and public health · 2023
   Pooled it
2. Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta-analysis of case-control studies.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
   Pooled it
3. Case Report: Pancreatic toxoplasmosis: role of endoscopic ultrasound in diagnosis.Frontiers in gastroenterology (Lausanne, Switzerland) · 2026
   Article
4. Fetomaternal and Pediatric Toxoplasmosis.Journal of pediatric infectious diseases · 2017
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

Indexed as